Literature DB >> 34917319

Cystic fibrosis and the gut.

Mordechai Slae1, Michael Wilschanski1.   

Abstract

Cystic fibrosis (CF) is a recessive disease caused by mutations in the CF transmembrane conductance regulator (CFTR) gene. The gene product, CFTR protein, has important manifestations in the intestine, pancreas and hepatobiliary system. Increased survival has caused CF to be primarily an adult disease today. Physicians must be knowledgeable as to the varied phenotype in the gastrointestinal tract. This review will outline the main gastrointestinal manifestations including a section on gastrointestinal malignancy in CF. Novel treatments treating the basic effect in CF are now being introduced and their effects on the gastrointestinal tract are discussed. © Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  cancer syndromes; chronic liver disease; cystic fibrosis; pancreatic disease

Year:  2020        PMID: 34917319      PMCID: PMC8640436          DOI: 10.1136/flgastro-2020-101610

Source DB:  PubMed          Journal:  Frontline Gastroenterol        ISSN: 2041-4137


  34 in total

1.  Cystic fibrosis.

Authors:  Steven M Rowe; Stacey Miller; Eric J Sorscher
Journal:  N Engl J Med       Date:  2005-05-12       Impact factor: 91.245

Review 2.  Patterns of GI disease in adulthood associated with mutations in the CFTR gene.

Authors:  Michael Wilschanski; Peter R Durie
Journal:  Gut       Date:  2007-04-19       Impact factor: 23.059

3.  CFTR is a tumor suppressor gene in murine and human intestinal cancer.

Authors:  B L N Than; J F Linnekamp; T K Starr; D A Largaespada; A Rod; Y Zhang; V Bruner; J Abrahante; A Schumann; T Luczak; A Niemczyk; M G O'Sullivan; J P Medema; R J A Fijneman; G A Meijer; E Van den Broek; C A Hodges; P M Scott; L Vermeulen; R T Cormier
Journal:  Oncogene       Date:  2016-01-11       Impact factor: 9.867

4.  A CFTR potentiator in patients with cystic fibrosis and the G551D mutation.

Authors:  Bonnie W Ramsey; Jane Davies; N Gerard McElvaney; Elizabeth Tullis; Scott C Bell; Pavel Dřevínek; Matthias Griese; Edward F McKone; Claire E Wainwright; Michael W Konstan; Richard Moss; Felix Ratjen; Isabelle Sermet-Gaudelus; Steven M Rowe; Qunming Dong; Sally Rodriguez; Karl Yen; Claudia Ordoñez; J Stuart Elborn
Journal:  N Engl J Med       Date:  2011-11-03       Impact factor: 91.245

5.  Reduction of Recurrence Risk of Pancreatitis in Cystic Fibrosis With Ivacaftor: Case Series.

Authors:  Andres Carrion; Drucy S Borowitz; Steven D Freedman; Christopher M Siracusa; Jennifer L Goralski; Denis Hadjiliadis; Saumini Srinivasan; Dennis C Stokes
Journal:  J Pediatr Gastroenterol Nutr       Date:  2018-03       Impact factor: 2.839

6.  Genotype and phenotype correlations in patients with cystic fibrosis and pancreatitis.

Authors:  Carol Durno; Mary Corey; Julian Zielenski; Elizabeth Tullis; Lap-Chee Tsui; Peter Durie
Journal:  Gastroenterology       Date:  2002-12       Impact factor: 22.682

7.  Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR.

Authors:  Claire E Wainwright; J Stuart Elborn; Bonnie W Ramsey; Gautham Marigowda; Xiaohong Huang; Marco Cipolli; Carla Colombo; Jane C Davies; Kris De Boeck; Patrick A Flume; Michael W Konstan; Susanna A McColley; Karen McCoy; Edward F McKone; Anne Munck; Felix Ratjen; Steven M Rowe; David Waltz; Michael P Boyle
Journal:  N Engl J Med       Date:  2015-05-17       Impact factor: 91.245

Review 8.  Meconium ileus in Cystic Fibrosis.

Authors:  Meghana Sathe; Roderick Houwen
Journal:  J Cyst Fibros       Date:  2017-11       Impact factor: 5.482

9.  Impact of CFTR modulation with Ivacaftor on Gut Microbiota and Intestinal Inflammation.

Authors:  Chee Y Ooi; Saad A Syed; Laura Rossi; Millie Garg; Bronwen Needham; Julie Avolio; Kelsey Young; Michael G Surette; Tanja Gonska
Journal:  Sci Rep       Date:  2018-12-13       Impact factor: 4.379

10.  Gastroesophageal reflux in cystic fibrosis across the age spectrum.

Authors:  Frederick W Woodley; Don Hayes; Benjamin T Kopp; Melissa Moore-Clingenpeel; Rodrigo Strehl Machado; Christopher J Nemastil; Sudarshan Jadcherla; Carlo Di Lorenzo; Ajay Kaul; Hayat Mousa
Journal:  Transl Gastroenterol Hepatol       Date:  2019-09-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.